jueves, 4 de julio de 2013

Announcements: National Cleft and Craniofacial Awareness and Prevention Month

Announcements: National Cleft and Craniofacial Awareness and Prevention Month

HHS, CDC and MMWR Logos
MMWR Weekly
Volume 62, No. 26
July 5, 2013

Announcements: National Cleft and Craniofacial Awareness and Prevention Month


July 5, 2013 / 62(26);543

Annually, approximately 7,000 U.S. infants are born with a cleft palate alone or a cleft lip with or without cleft palate (1). Other common craniofacial birth defects include craniosynostosis (when the skull sutures fuse prematurely) and microtia/anotia (when an infant's ear is small and poorly formed or missing). To increase awareness about these conditions, July is designated as National Cleft and Craniofacial Awareness and Prevention Month.
CDC and its partners work to better understand causes of cleft and craniofacial defects and how these conditions affect children and their families by focusing on risk factors, health-care service use, access to care, quality of life, health outcomes, and management and treatment of these conditions. Research has identified risk factors for cleft lip with or without cleft palate, including maternal diabetes (2), smoking (3), and certain medications (4,5). For craniosynostosis, research has shown an increased risk associated with maternal thyroid disease or its treatment during pregnancy (6). Parameters of care recently were developed to help treat children with craniosynostosis (7).
Health-care providers should encourage patients who are thinking about becoming pregnant to control diagnosed diabetes and quit smoking, and should work with patients to make informed decisions about medication treatment during pregnancy. Information regarding National Cleft and Craniofacial Awareness and Prevention Month is available at http://www.nccapm.org/about.htmlExternal Web Site Icon. Additional information on craniofacial birth defects is available at http://www.cdc.gov/ncbddd/features/cleft-awareness-july2013.html.


  1. Parker SE, Mai CT, Canfield MA, et al.; National Birth Defects Prevention Network. Updated national birth prevalence estimates for selected birth defects in the United States, 2004–2006. Birth Defects Res A Clin Mol Teratol 2010;88:1008–16.
  2. Correa A, Gilboa SM, Besser LM, et al. Diabetes mellitus and birth defects. Am J Obstet Gynecol 2008;199:237.e1–9.
  3. Honein MA, Rasmussen SA, Reefhuis J, et al. Maternal smoking, environmental tobacco smoke, and the risk of oral clefts. Epidemiology 2007;18:226–33.
  4. Margulis AV, Mitchell AA, Gilboa SM, et al. Use of topiramate in pregnancy and risk of oral clefts. Am J Obstet Gynecol 2012;207:405.e1–7.
  5. Reefhuis J, Honein MA, Schieve LA, Rasmussen SA; the National Birth Defects Prevention Study. Use of clomiphene citrate and birth defects, National Birth Defects Prevention Study, 1997–2005. Hum Reprod 2011;26:451–7.
  6. Rasmussen SA, Yazdy MM, Carmichael SL, Jamieson DJ, Canfield MA, Honein MA. Maternal thyroid disease as a risk factor for craniosynostosis. Obstet Gynecol 2007;110:369–77.
  7. McCarthy JG, Warren SM, Bernstein J, et al.; Craniosynostosis Working Group. Parameters of care for craniosynostosis. Cleft Palate Craniofac J 2012;49:1S–24S.

No hay comentarios:

Publicar un comentario